Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Validation Center for Precision Medicine with AI…

U.S. National Institutes of Health·United States of America

Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)

Closes 10/2/2026$2M – $2.7MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking applications for a Validation Center to support the development of innovative, reliable, and cost-effective AI-based tools that integrate clinical imaging with other health data types to enhance personalized medicine for patients with chronic and other health conditions. The Validation Center will serve as an independent hub for third-party verification, validation, and uncertainty quantification of AI-enabled, image-based, multimodal Clinical Decision Support (CDS) tools. Key responsibilities of the Validation Center include the systematic validation of PRIMED-AI Consortium deliverables, verification, validation, interoperability, and uncertainty quantification to comprehensively characterize performance of the CDS tools. Some key points to consider: • The Validation Center will focus on verification, validation, interoperability, and uncertainty quantification to comprehensively characterize performance of the CDS tools developed by the program. • The Validation Center will involve the systematic validation of PRIMED-AI Consortium deliverables. • Applicants must provide a Data Management and Sharing Plan, which must address the elements in the structured format. • The award recipient is solely responsible for the timely acquisition of all appropriate proprietary rights, including intellectual property rights, and all materials needed for the award recipient to perform the project. • The award recipient is required to report to the U.S. Government all inventions made in the performance of the project, as specified by 35 U.S.C. Sect. 202 (Bayh-Dole Act).

Attached files

Contact

Sahana N. Kukke, PhD(Program Contact)

[email protected]

(301) 402-3756

Key dates

Opened
6/6/2025
Closes
10/2/2026
Projected award
12/1/2026
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-RM-27-014

Budget estimate

$2,000,000 – $2,700,000

Based on the information provided, the estimated funding for this opportunity is $2,700,000. However, the award ceiling is $2,000,000. Considering the scope of the project and the requirements for the Validation Center, it is likely that the actual budget will be closer to the estimated funding amount. Factors that may influence the likely payment range include the complexity of the project, the number of applicants, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 74%

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

Closes 2/9/2027Opened 8/20/2026

U.S. National Institutes of Health·United States of America

73% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. National Institutes of Health·United States of America

71% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. Food and Drug Administration·United States of America

70% match

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

70% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

69% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

69% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

69% match

Data Coordinating Center for the Aging and Alzheimer?s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 6/20/2025

U.S. National Institutes of Health·United States of America

69% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

68% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

68% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. National Institutes of Health·United States of America

68% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. Agency for Health Care Research and Quality·United States of America

68% match

Examining the Impact of Artificial Intelligence (AI) on Healthcare Safety (R18)

Closes 5/25/2027Opened 7/16/2024

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. Food and Drug Administration·United States of America

68% match

Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 11/20/2023

U.S. Department Of Defense·United States of America

67% match

Profiling Action And Readiness Tracking Unified System (PARATUS) CSO

Closes 7/20/2028Opened 7/20/2026

U.S. National Institutes of Health·United States of America

67% match

NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)

Closes 3/1/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

67% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

67% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. Department Of Health And Human Services·Maryland

67% match

NIA:Non-Competitive Combined Synopsis/Solicitation

Closes 11/6/2026Opened 10/28/2026

U.S. Department Of Homeland Security·United States of America

67% match

Advanced Imaging Technology (AIT) Qualified Product List (QPL)

Closes 1/30/2027Opened 1/30/2026

U.S. National Institutes of Health·United States of America

67% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

67% match

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

Closes 1/27/2027Opened 1/30/2026

U.S. Department Of Health And Human Services·United States of America

67% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026